Target intelligence / Profile preview

Hemagglutinin protein of influenza A virus (H1 subtype) (HA)

Target
HA
Molecular classification
Viral protein, Glycoprotein, Class I viral fusion protein
01

Overview

Hemagglutinin (HA) is a surface glycoprotein on influenza A viruses, specifically the H1 subtype in this case. It mediates viral entry into host cells through receptor binding and membrane fusion. HA is a key target for neutralizing antibodies and is the primary antigen used in influenza vaccines. Its high variability due to antigenic drift and shift contributes to seasonal epidemics and pandemic potential.

Other names
H1 hemagglutininHA protein (H1 subtype)Influenza A H1 hemagglutinin
02

Mechanism of action

Vaccines induce neutralizing antibodies against HA, preventing receptor binding and viral entry. NA inhibitors prevent the release of newly formed virions from infected cells. Blocking viral entry, for example with fusion inhibitors.

03

Biological functions

Receptor bindingMembrane fusionViral entryHemagglutination
04

Disease associations

InfectionInfluenzaPandemic
05

Safety considerations

Antigenic drift (reduced vaccine efficacy)Antigenic shift (pandemic potential)Potential for vaccine mismatchAllergic reaction to vaccine components
06

Interacting drugs

Influenza vaccines

1 more in the full profile.

07

Biomarkers

Anti-HA antibody titers (vaccine efficacy)HA sequence (strain identification, vaccine matching)

Beyond the preview

Go deeper on Hemagglutinin protein of influenza A virus (H1 subtype) (HA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemagglutinin protein of influenza A virus (H1 subtype) (HA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call